Pharmacological Inhibition of PPAR&lt;sub&gt;y&lt;/sub&gt; Boosts HIV Reactivation and Th17 Effector Functions, while Preventing Progeny Virion Release and &lt;i&gt;de novo&lt;/i&gt; Infection
Pathogens & immunity